Skip to content
Screener

Financing Cash Flow at other companies

Eli Lilly logo
Eli LillyLLY
$8.43B+777%
AbbVie logo
AbbVieABBV
$919M+173%
Apyx Medical Corporation logo
Apyx Medical CorporationAPYX
$83K+232%
Establishment Labs logo
Establishment LabsESTA
$23.46M+357%
Bausch Health Companies logo
Bausch Health CompaniesBHC
-$100M+31.5%

Other financials

Income statement

See full
Revenue$42.9M-2.5%
Gross profit$26.3M-1.8%
Operating income-$29.0K-104%
Net income-$1.1M-88.2%
EPS (diluted)-$0.02-100%

Balance sheet

See full
Cash & equivalents$18.8M+130%
Total debt$70.5M-17.4%
Total equity$104.8M+16.4%
Total assets$193.3M-2.6%

Cash flow

See full
Operating cash flow$5.3M+507%
CapEx$228.0K-14.0%
Free cash flow$5.2M+605%

Valuation

See full
Market cap$194M-50.2%
Enterprise value$245.64M-47.4%
P/S1.3×-1.1×

Profitability

See full
Gross margin59.7%+0.6pp
Operating margin-8.4%+14.7pp
Net margin-11.3%-25.1pp
FCF margin-0.1%

Returns & leverage

See full
Return on equity-21.6%-78.3pp
Debt / equity0.7×-0.3×
Current ratio0.8×+0.2×

Where this comes from

Reported directly by AirSculpt Technologies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The source filing: AirSculpt Technologies, Inc.’s 10-Q, filed August 10, 2026.

Filed
Aug 10, 2026, 9:37 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001870940-26-000038
Line itemSix Months Ended June 30,Six Months Ended June 30,Six Months Ended June 30,Six Months Ended June 30,
Proceeds from public offerings, net19,56614,008
Payment of taxes withheld through vested equity-based compensation(195)(56)
Other financing activity(474)
Net cash provided by/(used in) financing activities6,621(3,732)
Net increase/(decrease) in cash and cash equivalents10,375(46)
Cash and cash equivalents
Beginning of period8,4498,235
End of period$$18,824$$8,189

Item 1. Financial Statements

FAQ

What is AirSculpt Technologies, Inc.'s financing cash flow?
AirSculpt Technologies, Inc. (AIRS) reported financing cash flow of $3.6M in Q2 2026.
How has AirSculpt Technologies, Inc.'s financing cash flow changed year-over-year?
AirSculpt Technologies, Inc.'s financing cash flow increased by 272.8% year-over-year, from -$2.08M to $3.6M.
What is the long-term trend for AirSculpt Technologies, Inc.'s financing cash flow?
Over 2 years (2022 to 2024), AirSculpt Technologies, Inc.'s financing cash flow has grown at a -84.8% compound annual growth rate (CAGR), from -$27.26M to $630K.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.

Ask your AI about AirSculpt Technologies, Inc.'s financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude